Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) SHH
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Jiangsu Hengrui Medicine Co., Ltd.
Address
38 Huanghe Rd Eco & Tech Dev Park
Lianyungang, 222000
China
Phone
86 518 8122 0983
Website
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
20238
First IPO Date
October 18, 2000
Key Executives
| Name | Title | Pay | Year Born |
| Lian Shan Zhang | Executive Vice President & Executive Director | 0 | 1962 |
| Ningjun Jiang | Executive Vice President, Chief Strategy Officer & Executive Director | 0 | 1961 |
| Cheng Liao | Deputy General Manager | 0 | 1976 |
| Feng He | Deputy General Manager | 0 | 1967 |
| Ya Ping Shen | Deputy General Manager | 0 | 1964 |
| Hong Bin Dai | Executive Deputy Chairman of the Board | 0 | 1976 |
| Jie Ping Sun | Senior Vice President & Executive Director | 0 | 1970 |
| Kin Chun Lau | Chief Financial Officer | 0 | 1979 |
| Piao Yang Sun | Executive Chairman of the Board | 0 | 1958 |
| Xiao Han Liu | Board Secretary | 0 | 1985 |
Description
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
